Avanos Medical
AVNS
277 hedge funds and large institutions have $623M invested in Avanos Medical in 2025 Q1 according to their latest regulatory filings, with 56 funds opening new positions, 76 increasing their positions, 77 reducing their positions, and 32 closing their positions.
75% more first-time investments, than exits
New positions opened: 56 | Existing positions closed: 32
7% more funds holding
Funds holding: 258 → 277 (+19)
0.31% more ownership
Funds ownership: 93.91% → 94.21% (+0.31%)
1% less repeat investments, than reductions
Existing positions increased: 76 | Existing positions reduced: 77
9% less capital invested
Capital invested by funds: $687M → $623M (-$64.5M)
75% less call options, than puts
Call options by funds: $50K | Put options by funds: $199K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$31.2M |
| 2 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$11.7M |
| 3 |
D.E. Shaw & Co
New York
|
+$9.28M |
| 4 |
CEI
Clark Estates Inc
New York
|
+$7.71M |
| 5 |
Millennium Management
New York
|
+$7.15M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RC
RGM Capital
Naples,
Florida
|
-$47.5M |
| 2 |
William Blair Investment Management
Chicago,
Illinois
|
-$20.1M |
| 3 |
WHG
Westwood Holdings Group
Dallas,
Texas
|
-$20.1M |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$7.26M |
| 5 |
BlackRock
New York
|
-$3.98M |
AVNS Hedge Fund Activity: Q1 2025 in Review
277 of the 7,457 institutional investors tracked by Wall St. Rank reported a position in Avanos Medical (AVNS) for Q1 2025, worth a combined $623M — down 9.4% from $687M a quarter earlier.
Buyers outnumbered sellers: 56 funds opened new AVNS positions and 32 closed out — a net gain of 24 holders — while 76 added to existing stakes and 77 trimmed.
The largest buyer was Armistice Capital, opening a new position worth an estimated $31.2M. The largest seller was RGM Capital, exiting entirely with an estimated $47.5M sold.
- 277 institutional investors held Avanos Medical (AVNS) as of Q1 2025, up from 258 in Q4 2024.
- Funds reported $623M of Avanos Medical stock for Q1 2025, down 9.4% quarter-over-quarter.
- 56 funds opened new Avanos Medical positions in Q1 2025 and 32 closed out, a net change of +24 holders.
- The largest Avanos Medical buyer in Q1 2025 was Armistice Capital, an estimated $31.2M added.
- The largest Avanos Medical seller in Q1 2025 was RGM Capital, an estimated $47.5M sold.
Based on aggregated 13F filings for Q1 2025.